Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Sep;26(9):1033-1039.
doi: 10.1002/pds.4297.

Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making

Marc L Berger  1 , Harold Sox  2 , Richard J Willke  3 , Diana L Brixner  4 , Hans-Georg Eichler  5 , Wim Goettsch  6 , David Madigan  7 , Amr Makady  6 , Sebastian Schneeweiss  8 , Rosanna Tarricone  9 , Shirley V Wang  8 , John Watkins  10 , C Daniel Mullins  11
Affiliations
Comparative Study

Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making

Marc L Berger et al. Pharmacoepidemiol Drug Saf. 2017 Sep.

Abstract

Purpose: Real-world evidence (RWE) includes data from retrospective or prospective observational studies and observational registries and provides insights beyond those addressed by randomized controlled trials. RWE studies aim to improve health care decision making.

Methods: The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the International Society for Pharmacoepidemiology (ISPE) created a task force to make recommendations regarding good procedural practices that would enhance decision makers' confidence in evidence derived from RWD studies. Peer review by ISPOR/ISPE members and task force participants provided a consensus-building iterative process for the topics and framing of recommendations.

Results: The ISPOR/ISPE Task Force recommendations cover seven topics such as study registration, replicability, and stakeholder involvement in RWE studies. These recommendations, in concert with earlier recommendations about study methodology, provide a trustworthy foundation for the expanded use of RWE in health care decision making.

Conclusion: The focus of these recommendations is good procedural practices for studies that test a specific hypothesis in a specific population. We recognize that some of the recommendations in this report may not be widely adopted without appropriate incentives from decision makers, journal editors, and other key stakeholders.

Keywords: comparative effectiveness; decision making; guidelines; pharmacoepidemiology; real-world data; treatment effectiveness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Recommendations for good procedural practices for Hypothesis Evaluating Treatment Effectiveness Studies
See this image and copyright information in PMC

Comment in

References

    1. Garrison LP, Neumann PJ, Erickson P, Marshall D, Mullins CD. Using real‐world data for coverage and payment decisions: The ISPOR real‐world data task force report. Value Health. 2006;10(5):326‐335. - PubMed
    1. Makady A, de Boer A, Hillege H, Klungel O, Goettsch W. What is real‐world data? A review of definitions based on literature and stakeholder interviews. Value Health. 2017;20(7):858‐865. - PubMed
    1. Makady A, Ham RT, de Boer A, Hillege H, Klungel O, Goettsch W. GetReal Workpackage. Policies for use of real‐world data in health technology assessment (HTA): A comparative study of six HTA agencies. Value Health. 2017;20(4):520‐532. - PubMed
    1. Sherman RE, Anderson SA, Dal Pan GJ, et al. Real‐world evidence—what is it and what can it tell us? N Engl J Med. 2016;375(23):2293‐2297. - PubMed
    1. Brixner DI, Holtorf AP, Neumann PJ, Malone DC, Watkins JB. Standardizing quality assessment of observational studies for decision making in health care. J Manag Care Pharm. 2009;15(3):275‐283. Available at: http://www.amcp.org/data/jmcp/275‐283.pdf - PMC - PubMed

Publication types

MeSH terms